GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical development

Lisbeth B. Knudsen, Christina Bjenning, S Bregenholt, Richard D. Carr, C. Godtfredsen, Jens J. Holst, Per Olaf Huusfeldt, Marianne O. Larsen, Philip J. Larsen, Per F. Nielsen,

Drugs of the Future · 2001 · 35 citations · 0 references

Concepts